ATLANTIS: a Phase III study of lurbinectedin/doxorubicin...

  • Main
  • 2018 / 10
  • ATLANTIS: a Phase III study of lurbinectedin/doxorubicin...

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line

Farago, Anna F, Drapkin, Benjamin J, Lopez-Vilarino de Ramos, Jose Antonio, Galmarini, Carlos M, Núñez, Rafael, Kahatt, Carmen, Paz-Ares, Luis
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2018-0597
Date:
October, 2018
File:
PDF, 2.67 MB
english, 2018
Conversion to is in progress
Conversion to is failed